Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

CHMP Adopts Positive Opinion for Aflibercept, Pegfilgrastim Biosimilars:  On January 30, 2025, the European Medicines Agency (EMA) Committee ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...

The two products, both manufactured by Amgen, are aflibercept biosimilars Pavblu and Skojoy. Both biosimilars are indicated ...

Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...

The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.

AMSTERDAM, Jan 27 (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social ...

Simply sign up to the European banks myFT Digest -- delivered directly to your inbox. European banks are on course to return close to €123bn to shareholders for the second consecutive year as ...

EMA Partners IPO allotment date today: EMA Partners India IPO allotment share allotment will be finalised today (Wednesday, January 22). The investors who applied for the issue can check the EMA ...

Of the total EMA Partners IPO offer, 50% is reserved for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional investors. The proceeds will be used to meet ...